Clinical Trial Update: Dual Time Point FDG PET/MRI Scan in Improving the Imaging Cancer Patients With Brain Metastases [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing a dual time-point FDG PET/MRI protocol to improve imaging of brain metastases; trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Solid Tumor

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Metastatic Malignant Neoplasm in the Brain, Metastatic Malignant Solid Neoplasm | Phase 4 | Status: COMPLETED